Cargando…
Vaccines After an Emergency Use Authorization (EUA): Modern Evidence Generation Approaches
Every medical product requires additional study even after regulatory approval. We highlight several lines of enquiry to advance our understanding of COVID19 vaccines post authorization: identifying key population segments warranting more study, assessment of efficacy, and of safety data, harmonizat...
Autores principales: | Zariffa, Névine, Russek-Cohen, Estelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061154/ https://www.ncbi.nlm.nih.gov/pubmed/33886112 http://dx.doi.org/10.1007/s43441-021-00290-z |
Ejemplares similares
-
EUA /
por: Suárez Argüello, Ana Rosa
Publicado: (1988) -
Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords
por: Bhimraj, Adarsh, et al.
Publicado: (2021) -
EUA : sus novelas
por: Rodríguez Alvarez, Argentina
Publicado: (1994) -
Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic
por: Roncati, Luca, et al.
Publicado: (2021) -
EUA : historia de sus familias
por: Báez-Villaseñor, María Estela
Publicado: (1995)